InflaRx N.V. (IFRX)

USD 1.73

(-6.49%)

Total Assets Summary of InflaRx N.V.

  • InflaRx N.V.'s latest annual total assets in 2023 was 120.3 Million EUR , up 17.49% from previous year.
  • InflaRx N.V.'s latest quarterly total assets in 2024 Q2 was 93.09 Million EUR , down -13.21% from previous quarter.
  • InflaRx N.V. reported annual total assets of 102.39 Million EUR in 2022, down -18.17% from previous year.
  • InflaRx N.V. reported annual total assets of 125.13 Million EUR in 2021, up 41.86% from previous year.
  • InflaRx N.V. reported quarterly total assets of 107.19 Million EUR for 2024 Q1, down -10.9% from previous quarter.
  • InflaRx N.V. reported quarterly total assets of 86.31 Million EUR for 2023 Q1, down -15.71% from previous quarter.

Annual Total Assets Chart of InflaRx N.V. (2023 - 2015)

Historical Annual Total Assets of InflaRx N.V. (2023 - 2015)

Year Total Assets Total Assets Growth
2023 120.3 Million EUR 17.49%
2022 102.39 Million EUR -18.17%
2021 125.13 Million EUR 41.86%
2020 88.21 Million EUR -27.44%
2019 121.57 Million EUR -23.64%
2018 159.21 Million EUR 28.18%
2017 124.21 Million EUR 320.8%
2016 29.51 Million EUR 723.15%
2015 3.58 Million EUR 0.0%

Peer Total Assets Comparison of InflaRx N.V.

Name Total Assets Total Assets Difference
NeuroSense Therapeutics Ltd. 3.17 Million USD -3688.025%
Psyence Biomedical Ltd. 1.13 Million USD -10526.393%
XOMA Corporation 234.3 Million USD 48.653%
Mesoblast Limited 669.15 Million USD 82.021%
Xeris Biopharma Holdings, Inc. 340.79 Million USD 64.698%
Aptorum Group Limited 20.64 Million USD -482.883%
Qualigen Therapeutics, Inc. 2.03 Million USD -5817.018%
HilleVax, Inc. 344.43 Million USD 65.071%
Rocket Pharmaceuticals, Inc. 566.34 Million USD 78.757%
Corbus Pharmaceuticals Holdings, Inc. 28.27 Million USD -325.531%
Precision BioSciences, Inc. 159.78 Million USD 24.705%
Dyadic International, Inc. 8.21 Million USD -1363.733%
Intensity Therapeutics, Inc. 17.29 Million USD -595.621%
IDEAYA Biosciences, Inc. 649.31 Million USD 81.472%
Eton Pharmaceuticals, Inc. 31.74 Million USD -279.041%
VYNE Therapeutics Inc. 97.68 Million USD -23.159%
EyePoint Pharmaceuticals, Inc. 355.18 Million USD 66.128%
Adaptive Biotechnologies Corporation 661.13 Million USD 81.803%
Tenaya Therapeutics, Inc. 170.51 Million USD 29.445%
IGM Biosciences, Inc. 423.41 Million USD 71.586%
Opthea Limited 188.79 Million USD 36.275%
Milestone Pharmaceuticals Inc. 75.22 Million USD -59.928%
Abeona Therapeutics Inc. 64 Million USD -87.975%
Tonix Pharmaceuticals Holding Corp. 154.45 Million USD 22.109%
Ligand Pharmaceuticals Incorporated 833.06 Million USD 85.558%
NextCure, Inc. 129.41 Million USD 7.039%
Inhibikase Therapeutics, Inc. 14.5 Million USD -729.328%
Ovid Therapeutics Inc. 144.02 Million USD 16.469%
CASI Pharmaceuticals, Inc. 75.26 Million USD -59.839%
Arcturus Therapeutics Holdings Inc. 429.4 Million USD 71.983%
Syros Pharmaceuticals, Inc. 168.17 Million USD 28.462%
Senti Biosciences, Inc. 119.48 Million USD -0.689%
Apollomics, Inc. 55.38 Million USD -117.213%
PureTech Health plc 693.97 Million USD 82.664%
Oncternal Therapeutics, Inc. 36.72 Million USD -227.555%
Barinthus Biotherapeutics plc 214.5 Million USD 43.914%
Kymera Therapeutics, Inc. 575.75 Million USD 79.105%
ChromaDex Corporation 54.96 Million USD -118.884%
Monopar Therapeutics Inc. 7.34 Million USD -1537.918%
Akebia Therapeutics, Inc. 241.7 Million USD 50.225%
Sangamo Therapeutics, Inc. 165.32 Million USD 27.227%
Dermata Therapeutics, Inc. 7.97 Million USD -1407.873%
Gritstone bio, Inc. 177.76 Million USD 32.324%
Virpax Pharmaceuticals, Inc. 9.62 Million USD -1149.515%
Fate Therapeutics, Inc. 506.21 Million USD 76.234%
BioXcel Therapeutics, Inc. 73.7 Million USD -63.235%
Fortress Biotech, Inc. 167.52 Million USD 28.186%
Checkpoint Therapeutics, Inc. 5.37 Million USD -2137.033%
Atossa Therapeutics, Inc. 96.25 Million USD -24.992%
Lyell Immunopharma, Inc. 750.02 Million USD 83.96%
Celcuity Inc. 191.21 Million USD 37.084%
ContextLogic Inc. 423 Million USD 71.558%
GH Research PLC 226.3 Million USD 46.837%
HOOKIPA Pharma Inc. 161.33 Million USD 25.431%
Cassava Sciences, Inc. 151.66 Million USD 20.674%
Cyclacel Pharmaceuticals, Inc. 8.8 Million USD -1266.356%
ImmuCell Corporation 43.8 Million USD -174.624%
Amarin Corporation plc 831.68 Million USD 85.534%
TG Therapeutics, Inc. 329.58 Million USD 63.497%
X4 Pharmaceuticals, Inc. 147.25 Million USD 18.301%
Acelyrin, Inc. 742.69 Million USD 83.801%
BriaCell Therapeutics Corp. 5.87 Million USD -1948.745%
Seer, Inc. 436.26 Million USD 72.424%
Novavax, Inc. 1.85 Billion USD 93.516%
Phathom Pharmaceuticals, Inc. 413.84 Million USD 70.929%
Jazz Pharmaceuticals plc 11.39 Billion USD 98.944%
AnaptysBio, Inc. 452.38 Million USD 73.406%
Aptevo Therapeutics Inc. 24.84 Million USD -384.291%
PMV Pharmaceuticals, Inc. 252.15 Million USD 52.288%
AbCellera Biologics Inc. 1.48 Billion USD 91.915%
CorMedix Inc. 82.05 Million USD -46.609%
Cartesian Therapeutics, Inc. 305.05 Million USD 60.561%
Marker Therapeutics, Inc. 17.12 Million USD -602.428%
Regeneron Pharmaceuticals, Inc. 33.08 Billion USD 99.636%
Aptose Biosciences Inc. 12.92 Million USD -830.991%
ZyVersa Therapeutics, Inc. 22.11 Million USD -444.027%
Soligenix, Inc. 9.79 Million USD -1127.964%
Century Therapeutics, Inc. 360.69 Million USD 66.645%
Arrowhead Pharmaceuticals, Inc. 765.55 Million USD 84.285%
TransCode Therapeutics, Inc. 5.16 Million USD -2227.169%
Kura Oncology, Inc. 448.93 Million USD 73.202%
RAPT Therapeutics, Inc. 173.32 Million USD 30.59%
Ardelyx, Inc. 297.57 Million USD 59.571%
Ainos, Inc. 31.84 Million USD -277.829%
TScan Therapeutics, Inc. 272.14 Million USD 55.793%
Ocean Biomedical, Inc. 110.91 Million USD -8.472%
Prothena Corporation plc 696.38 Million USD 82.724%
CytomX Therapeutics, Inc. 205.15 Million USD 41.357%
Autolus Therapeutics plc 375.38 Million USD 67.951%
Mineralys Therapeutics, Inc. 251.63 Million USD 52.19%
Adaptimmune Therapeutics plc 282.61 Million USD 57.431%
Eterna Therapeutics Inc. 49.13 Million USD -144.866%
Celularity Inc. 143.88 Million USD 16.389%
Rallybio Corporation 115.62 Million USD -4.054%
GRI Bio, Inc. 2.95 Million USD -3969.948%
Xenetic Biosciences, Inc. 10.6 Million USD -1034.419%
Omeros Corporation 378.26 Million USD 68.195%
INmune Bio, Inc. 57 Million USD -111.062%
Heron Therapeutics, Inc. 222.5 Million USD 45.931%
SAB Biotherapeutics, Inc. 83.94 Million USD -43.324%
Pasithea Therapeutics Corp. 26.11 Million USD -360.651%
Entero Therapeutics, Inc. 6.88 Million USD -1647.846%
Humacyte, Inc. 128.22 Million USD 6.173%
Atara Biotherapeutics, Inc. 165.5 Million USD 27.308%
Coherus BioSciences, Inc. 629.6 Million USD 80.892%
Immunocore Holdings plc 597 Million USD 79.848%
Cocrystal Pharma, Inc. 31.25 Million USD -284.874%
Verastem, Inc. 149.71 Million USD 19.644%
Pliant Therapeutics, Inc. 512.15 Million USD 76.509%
Histogen Inc. 19.07 Million USD -530.775%
Surrozen, Inc. 46.08 Million USD -161.084%
Blueprint Medicines Corporation 1.04 Billion USD 88.534%
Organovo Holdings, Inc. 6.34 Million USD -1794.907%
Lixte Biotechnology Holdings, Inc. 4.3 Million USD -2692.255%
IO Biotech, Inc. 150.71 Million USD 20.177%
MEI Pharma, Inc. 41.37 Million USD -190.774%
GT Biopharma, Inc. 14.1 Million USD -752.702%
Centessa Pharmaceuticals plc 362.96 Million USD 66.855%
Hepion Pharmaceuticals, Inc. 18.09 Million USD -564.889%
Cabaletta Bio, Inc. 253.65 Million USD 52.569%
Summit Therapeutics Inc. 202.94 Million USD 40.72%
Alaunos Therapeutics, Inc. 8.26 Million USD -1355.98%
Marinus Pharmaceuticals, Inc. 170.9 Million USD 29.607%
BioRestorative Therapies, Inc. 12.61 Million USD -853.935%
Turnstone Biologics Corp. 112.81 Million USD -6.642%
Pulmatrix, Inc. 33.95 Million USD -254.284%
Synaptogenix, Inc. 31.11 Million USD -286.671%
Tiziana Life Sciences Ltd 12.18 Million USD -887.423%
Aurinia Pharmaceuticals Inc. 548.06 Million USD 78.049%
Vigil Neuroscience, Inc. 140.85 Million USD 14.589%
Intellia Therapeutics, Inc. 1.3 Billion USD 90.753%
Cytokinetics, Incorporated 824.31 Million USD 85.405%
Exelixis, Inc. 2.94 Billion USD 95.911%
Nurix Therapeutics, Inc. 364.53 Million USD 66.997%
Apellis Pharmaceuticals, Inc. 788.73 Million USD 84.747%
Evogene Ltd. 51.1 Million USD -135.431%
Replimune Group, Inc. 487.72 Million USD 75.333%
PDS Biotechnology Corporation 59.39 Million USD -102.572%
Hoth Therapeutics, Inc. 9.52 Million USD -1163.699%
Jasper Therapeutics, Inc. 95.38 Million USD -26.135%
ESSA Pharma Inc. 149.12 Million USD 19.323%
TNF Pharmaceuticals, Inc. 17.86 Million USD -573.53%
BioLineRx Ltd. 63.92 Million USD -88.201%
Avid Bioservices, Inc. 336.55 Million USD 64.253%
Insmed Incorporated 1.32 Billion USD 90.953%
VistaGen Therapeutics, Inc. 123.65 Million USD 2.705%
Zentalis Pharmaceuticals, Inc. 562.02 Million USD 78.594%
Sagimet Biosciences Inc. 96.71 Million USD -24.389%
MediWound Ltd. 66.45 Million USD -81.025%
MiMedx Group, Inc. 239.04 Million USD 49.672%
OmniAb, Inc. 401.98 Million USD 70.072%
Alector, Inc. 621.82 Million USD 80.653%
Seres Therapeutics, Inc. 358.6 Million USD 66.451%
PTC Therapeutics, Inc. 1.9 Billion USD 93.679%
Mereo BioPharma Group plc 66.49 Million USD -80.916%
Zai Lab Limited 1.03 Billion USD 88.391%
Revance Therapeutics, Inc. 478.45 Million USD 74.855%
Syndax Pharmaceuticals, Inc. 612.88 Million USD 80.37%
Aura Biosciences, Inc. 255.07 Million USD 52.834%
Immunic, Inc. 54.29 Million USD -121.565%
Dyne Therapeutics, Inc. 165.08 Million USD 27.122%
Tarsus Pharmaceuticals, Inc. 266.22 Million USD 54.81%
Veracyte, Inc. 1.13 Billion USD 89.426%
InMed Pharmaceuticals Inc. 11.82 Million USD -917.592%
FibroGen, Inc. 423.52 Million USD 71.594%
SeaStar Medical Holding Corporation 3.51 Million USD -3324.642%
Allakos Inc. 243.61 Million USD 50.615%
scPharmaceuticals Inc. 94.47 Million USD -27.338%
Fulcrum Therapeutics, Inc. 257.69 Million USD 53.314%
Corcept Therapeutics Incorporated 621.51 Million USD 80.643%
Adial Pharmaceuticals, Inc. 4.73 Million USD -2439.956%
NLS Pharmaceutics AG 1.84 Million USD -6414.946%
Sonnet BioTherapeutics Holdings, Inc. 5.42 Million USD -2115.824%
Amylyx Pharmaceuticals, Inc. 517.45 Million USD 76.75%
Precigen, Inc. 151.04 Million USD 20.349%
Fortrea Holdings Inc. 4.35 Billion USD 97.239%
KalVista Pharmaceuticals, Inc. 235.4 Million USD 48.893%
Incyte Corporation 6.78 Billion USD 98.226%
Alzamend Neuro, Inc. 631.58 Thousand USD -18948.44%
Cara Therapeutics, Inc. 125.84 Million USD 4.399%
XBiotech Inc. 227.24 Million USD 47.058%
Aligos Therapeutics, Inc. 153.9 Million USD 21.829%
Jasper Therapeutics, Inc. 95.38 Million USD -26.135%
Reviva Pharmaceuticals Holdings, Inc. 18.92 Million USD -535.752%
CRISPR Therapeutics AG 2.22 Billion USD 94.604%
Akero Therapeutics, Inc. 580.27 Million USD 79.267%
Eliem Therapeutics, Inc. 110.46 Million USD -8.906%
Lyra Therapeutics, Inc. 142.6 Million USD 15.633%
Foghorn Therapeutics Inc. 285.91 Million USD 57.922%
Agenus Inc. 313.91 Million USD 61.675%
Kiora Pharmaceuticals, Inc. 13.71 Million USD -777.398%
Y-mAbs Therapeutics, Inc. 127.86 Million USD 5.913%
Theravance Biopharma, Inc. 381.99 Million USD 68.506%
Ultragenyx Pharmaceutical Inc. 1.49 Billion USD 91.931%
Metagenomi, Inc. Common Stock 364.84 Million USD 67.025%
Lexaria Bioscience Corp. 3.08 Million USD -3801.044%
BioCryst Pharmaceuticals, Inc. 516.96 Million USD 76.728%
UroGen Pharma Ltd. 178.31 Million USD 32.529%
Gain Therapeutics, Inc. 18.6 Million USD -546.491%
Sutro Biopharma, Inc. 470.73 Million USD 74.443%
Creative Medical Technology Holdings, Inc. 10.71 Million USD -1022.777%
Lisata Therapeutics, Inc. 54.69 Million USD -119.965%
Chemomab Therapeutics Ltd. 22.15 Million USD -443.122%
Stoke Therapeutics, Inc. 228.34 Million USD 47.313%
Chimerix, Inc. 212.77 Million USD 43.458%
Reneo Pharmaceuticals, Inc. 107.43 Million USD -11.981%
Outlook Therapeutics, Inc. 32.3 Million USD -272.458%
60 Degrees Pharmaceuticals, Inc. 7.78 Million USD -1445.622%
Pluri Inc. 39.52 Million USD -204.368%
Cue Biopharma, Inc. 61.53 Million USD -95.527%
MeiraGTx Holdings plc 458.16 Million USD 73.742%
Aprea Therapeutics, Inc. 22.65 Million USD -431.156%
Cadrenal Therapeutics, Inc. Common Stock 8.51 Million USD -1312.186%
Cidara Therapeutics, Inc. 68.53 Million USD -75.555%
ProMIS Neurosciences, Inc. 18.04 Million USD -566.711%
CalciMedica, Inc. 12.18 Million USD -887.342%
Scholar Rock Holding Corporation 311.03 Million USD 61.32%
Sana Biotechnology, Inc. 565.29 Million USD 78.718%
Elicio Therapeutics, Inc. 27.14 Million USD -343.187%
NLS Pharmaceutics AG 1.84 Million USD -6414.946%
Adlai Nortye Ltd. American Depositary Shares 130.18 Million USD 7.59%
Nutriband Inc. 7.51 Million USD -1500.442%
Protara Therapeutics, Inc. 78.95 Million USD -52.377%
Vor Biopharma Inc. 209.82 Million USD 42.664%
Roivant Sciences Ltd. 7.22 Billion USD 98.334%
ProKidney Corp. 420.55 Million USD 71.393%
Applied Therapeutics, Inc. 54.83 Million USD -119.407%
Daré Bioscience, Inc. 21.28 Million USD -465.297%
BridgeBio Pharma, Inc. 546.38 Million USD 77.981%
Titan Pharmaceuticals, Inc. 8.08 Million USD -1387.851%
Bicycle Therapeutics plc 595.34 Million USD 79.792%
Tango Therapeutics, Inc. 402.56 Million USD 70.115%
Galectin Therapeutics Inc. 28.2 Million USD -326.623%
Revolution Medicines, Inc. Warrant 2.08 Billion USD 94.24%
Atai Life Sciences N.V. 293.47 Million USD 59.006%
Renovaro Biosciences Inc. 163.12 Million USD 26.25%
Aerovate Therapeutics, Inc. 127.41 Million USD 5.58%
MediciNova, Inc. 66.26 Million USD -81.542%
Praxis Precision Medicines, Inc. 87.94 Million USD -36.794%
Cardio Diagnostics Holdings, Inc. 4.46 Million USD -2596.052%
GeoVax Labs, Inc. 9.28 Million USD -1195.969%
Protagonist Therapeutics, Inc. 357.95 Million USD 66.39%
Axsome Therapeutics, Inc. 588.23 Million USD 79.548%
Biomea Fusion, Inc. 199.92 Million USD 39.824%
RenovoRx, Inc. 1.46 Million USD -8106.525%
Erasca, Inc. 395.29 Million USD 69.565%
Cullinan Oncology, Inc. 485.09 Million USD 75.199%
NRx Pharmaceuticals, Inc. 7.31 Million USD -1544.671%
4D Molecular Therapeutics, Inc. 339.89 Million USD 64.604%
Kiniksa Pharmaceuticals, Ltd. 526.32 Million USD 77.142%
bluebird bio, Inc. 619.16 Million USD 80.569%
Ventyx Biosciences, Inc. 277.69 Million USD 56.676%
Pieris Pharmaceuticals, Inc. 38.68 Million USD -211.033%
Imunon, Inc. 21.91 Million USD -448.897%
BioMarin Pharmaceutical Inc. 6.84 Billion USD 98.242%
BioAtla, Inc. 119.65 Million USD -0.543%
Allogene Therapeutics, Inc. 642.83 Million USD 81.285%
Larimar Therapeutics, Inc. 95.93 Million USD -25.405%
DBV Technologies S.A. 182.98 Million USD 34.253%
Fortress Biotech, Inc. 167.52 Million USD 28.186%
Avidity Biosciences, Inc. 628.55 Million USD 80.86%
Kezar Life Sciences, Inc. 221.23 Million USD 45.62%
aTyr Pharma, Inc. 122.06 Million USD 1.441%
Viridian Therapeutics, Inc. 490.42 Million USD 75.469%
EyeGate Pharmaceuticals, Inc. 15.15 Million USD -693.714%
Galecto, Inc. 38.22 Million USD -214.719%
Akari Therapeutics, Plc 4.35 Million USD -2662.518%
Tevogen Bio Holdings Inc. 17.03 Million USD -606.141%
Halozyme Therapeutics, Inc. 1.73 Billion USD 93.059%
Lexicon Pharmaceuticals, Inc. 229.42 Million USD 47.562%
Entera Bio Ltd. 11.76 Million USD -922.59%
Travere Therapeutics, Inc. 788.91 Million USD 84.75%
Sensei Biotherapeutics, Inc. 74.37 Million USD -61.76%
Xencor, Inc. 952.69 Million USD 87.372%
Orchestra BioMed Holdings, Inc. 95.21 Million USD -26.358%
Spruce Biosciences, Inc. 103.94 Million USD -15.741%
Coeptis Therapeutics Holdings, Inc. 8.07 Million USD -1390.6%
Vanda Pharmaceuticals Inc. 648.44 Million USD 81.447%
Lexaria Bioscience Corp. 3.08 Million USD -3801.044%
Portage Biotech Inc. 7.77 Million USD -1446.57%
Cardio Diagnostics Holdings, Inc. 4.46 Million USD -2596.052%
Olema Pharmaceuticals, Inc. 276.94 Million USD 56.559%
OncoCyte Corporation 74.89 Million USD -60.642%
Processa Pharmaceuticals, Inc. 5.78 Million USD -1979.058%
Purple Biotech Ltd. 44.3 Million USD -171.563%
CollPlant Biotechnologies Ltd. 34.12 Million USD -252.54%
Onconetix, Inc. 88.82 Million USD -35.449%
MacroGenics, Inc. 306.82 Million USD 60.789%
Tharimmune, Inc. 10.94 Million USD -999.062%
Genprex, Inc. 10.67 Million USD -1027.469%
Apogee Therapeutics, Inc. 401.4 Million USD 70.028%
Neumora Therapeutics, Inc. Common Stock 496.19 Million USD 75.754%
Ocuphire Pharma, Inc. 53.94 Million USD -123.007%
Prime Medicine, Inc. 193.85 Million USD 37.938%
Aditxt, Inc. 44.57 Million USD -169.879%
XTL Biopharmaceuticals Ltd. 2.42 Million USD -4859.096%
Virios Therapeutics, Inc. 4.16 Million USD -2788.233%
OKYO Pharma Limited 1.54 Million USD -7705.779%
Savara Inc. 177.56 Million USD 32.245%
Curis, Inc. 77.28 Million USD -55.674%
Carmell Therapeutics Corporation 63.94 Million USD -88.131%
Adagene Inc. 115.72 Million USD -3.957%
Achieve Life Sciences, Inc. 19.37 Million USD -521.071%
BeiGene, Ltd. 5.8 Billion USD 97.928%
Inhibrx Biosciences, Inc. 307.89 Million USD 60.925%
GlycoMimetics, Inc. 45.31 Million USD -165.483%
Maravai LifeSciences Holdings, Inc. 1.48 Billion USD 91.912%
Protagenic Therapeutics, Inc. 4.32 Million USD -2682.729%
SciSparc Ltd. 11.18 Million USD -975.905%
Protagenic Therapeutics, Inc. 4.32 Million USD -2682.729%
Vincerx Pharma, Inc. 18.21 Million USD -560.414%
Revelation Biosciences, Inc. 12.21 Million USD -885.11%
Minerva Neurosciences, Inc. 56.9 Million USD -111.435%
Fresh Tracks Therapeutics, Inc. 11.58 Million USD -938.388%
Arcutis Biotherapeutics, Inc. 341.36 Million USD 64.757%
Acrivon Therapeutics, Inc. Common Stock 138.26 Million USD 12.988%
Alnylam Pharmaceuticals, Inc. 3.82 Billion USD 96.859%
ADMA Biologics, Inc. 329.18 Million USD 63.453%
Rigel Pharmaceuticals, Inc. 117.22 Million USD -2.63%
Clene Inc. 52.34 Million USD -129.854%
Celldex Therapeutics, Inc. 465.62 Million USD 74.162%
Cogent Biosciences, Inc. 313.43 Million USD 61.617%
Boundless Bio, Inc. Common Stock 129.89 Million USD 7.38%
Recursion Pharmaceuticals, Inc. 653.69 Million USD 81.596%
Adicet Bio, Inc. 207.29 Million USD 41.963%
Contineum Therapeutics, Inc. Class A Common Stock 130.38 Million USD 7.73%
Absci Corporation 234.48 Million USD 48.692%
Estrella Immunopharma, Inc. 4.45 Million USD -2601.0%
Quantum-Si incorporated 298.25 Million USD 59.662%
Acurx Pharmaceuticals, Inc. 7.7 Million USD -1460.588%
Voyager Therapeutics, Inc. 351.28 Million USD 65.752%
Surrozen, Inc. 46.08 Million USD -161.084%
Generation Bio Co. 374.75 Million USD 67.897%
Astria Therapeutics, Inc. 254.66 Million USD 52.759%
Caribou Biosciences, Inc. 440.96 Million USD 72.717%
Black Diamond Therapeutics, Inc. 158.56 Million USD 24.128%
Janux Therapeutics, Inc. 380.4 Million USD 68.374%
Invivyd, Inc. 229.18 Million USD 47.505%
Cingulate Inc. 3.49 Million USD -3345.793%
Relay Therapeutics, Inc. 843.98 Million USD 85.745%
Quoin Pharmaceuticals, Ltd. 12.16 Million USD -888.616%
Tenax Therapeutics, Inc. 11.68 Million USD -929.623%
Spero Therapeutics, Inc. 182.39 Million USD 34.038%
Jaguar Health, Inc. 50.76 Million USD -136.999%
Artelo Biosciences, Inc. 20.42 Million USD -489.05%
2seventy bio, Inc. 565.42 Million USD 78.723%
Clearside Biomedical, Inc. 34.01 Million USD -253.659%
Terns Pharmaceuticals, Inc. 268.51 Million USD 55.196%
ACADIA Pharmaceuticals Inc. 748.95 Million USD 83.937%
Capricor Therapeutics, Inc. 58.73 Million USD -104.834%
Citius Pharmaceuticals, Inc. 103.61 Million USD -16.115%
Relmada Therapeutics, Inc. 97.55 Million USD -23.327%
Kronos Bio, Inc. 213.27 Million USD 43.591%
Innoviva, Inc. 1.24 Billion USD 90.325%
Bolt Biotherapeutics, Inc. 159.78 Million USD 24.706%
Entrada Therapeutics, Inc. 469.19 Million USD 74.359%
ALX Oncology Holdings Inc. 242.55 Million USD 50.399%
Vir Biotechnology, Inc. 1.96 Billion USD 93.862%
Evaxion Biotech A/S 12.88 Million USD -833.441%
Ocular Therapeutix, Inc. 252.06 Million USD 52.27%
Verve Therapeutics, Inc. 752.68 Million USD 84.016%
Tyra Biosciences, Inc. 225.85 Million USD 46.733%
Galmed Pharmaceuticals Ltd. 16.62 Million USD -623.481%
Unity Biotechnology, Inc. 65.69 Million USD -83.145%
Connect Biopharma Holdings Limited 125.89 Million USD 4.436%
Clearmind Medicine Inc. 4.32 Million USD -2682.073%
AlloVir, Inc. 190.79 Million USD 36.944%
ORIC Pharmaceuticals, Inc. 254.68 Million USD 52.762%
Catalyst Pharmaceuticals, Inc. 471.9 Million USD 74.506%
CERo Therapeutics Holdings, Inc. 8.56 Million USD -1305.363%
Viking Therapeutics, Inc. 368.49 Million USD 67.351%
Keros Therapeutics, Inc. 370.02 Million USD 67.487%
SELLAS Life Sciences Group, Inc. 6.4 Million USD -1778.926%
Crinetics Pharmaceuticals, Inc. 635.35 Million USD 81.064%
ImmunityBio, Inc. 504.45 Million USD 76.151%
Korro Bio, Inc. 221.66 Million USD 45.725%
C4 Therapeutics, Inc. 376.45 Million USD 68.042%
Kineta, Inc. 10.28 Million USD -1070.194%
Lantern Pharma Inc. 43.64 Million USD -175.634%
BioVie Inc. 25.2 Million USD -377.253%
Codexis, Inc. 136.56 Million USD 11.902%
Celularity Inc. 143.88 Million USD 16.389%
Eledon Pharmaceuticals, Inc. 125.89 Million USD 4.437%
Virax Biolabs Group Limited 5.48 Million USD -2093.806%
Kodiak Sciences Inc. 479.37 Million USD 74.903%
Cibus, Inc. 544.41 Million USD 77.901%
Annexon, Inc. 297.67 Million USD 59.584%
Assembly Biosciences, Inc. 137.46 Million USD 12.484%
Moderna, Inc. 18.42 Billion USD 99.347%
Ionis Pharmaceuticals, Inc. 2.99 Billion USD 95.976%
Adverum Biotechnologies, Inc. 173.01 Million USD 30.462%
Avalo Therapeutics, Inc. 20.99 Million USD -473.085%
Immix Biopharma, Inc. 19.92 Million USD -503.798%
Eyenovia, Inc. 28.77 Million USD -318.034%
Puma Biotechnology, Inc. 230.52 Million USD 47.812%
Monte Rosa Therapeutics, Inc. 303.75 Million USD 60.393%
Wave Life Sciences Ltd. 274.94 Million USD 56.244%
Conduit Pharmaceuticals Inc. 7.22 Million USD -1565.388%
Xilio Therapeutics, Inc. 60.92 Million USD -97.465%
Alkermes plc 2.13 Billion USD 94.368%
Arcellx, Inc. 825.13 Million USD 85.42%
Moolec Science SA 24.05 Million USD -400.213%
Cardiff Oncology, Inc. 81.63 Million USD -47.369%
LAVA Therapeutics N.V. 101.71 Million USD -18.285%
Enanta Pharmaceuticals, Inc. 462.27 Million USD 73.975%
Regulus Therapeutics Inc. 30.75 Million USD -291.244%
Atea Pharmaceuticals, Inc. 594.96 Million USD 79.779%
Compass Therapeutics, Inc. 156.87 Million USD 23.31%
Greenwich LifeSciences, Inc. 6.99 Million USD -1619.955%
Humacyte, Inc. 128.22 Million USD 6.173%
Acumen Pharmaceuticals, Inc. 310.12 Million USD 61.207%
Geron Corporation 394.07 Million USD 69.471%
Verrica Pharmaceuticals Inc. 81.59 Million USD -47.441%
Avenue Therapeutics, Inc. 1.85 Million USD -6403.117%
Royalty Pharma plc 16.38 Billion USD 99.266%
TFF Pharmaceuticals, Inc. 12.02 Million USD -900.287%
Notable Labs, Ltd. 19.54 Million USD -515.668%
Mersana Therapeutics, Inc. 226.06 Million USD 46.781%
Structure Therapeutics Inc. 482.01 Million USD 75.041%
IN8bio, Inc. 33.7 Million USD -256.901%
89bio, Inc. 596.26 Million USD 79.823%
DiaMedica Therapeutics Inc. 54.16 Million USD -122.134%
Vera Therapeutics, Inc. 175.54 Million USD 31.467%
Acasti Pharma Inc. 73.3 Million USD -64.131%
Genelux Corporation 27.89 Million USD -331.318%
Trevi Therapeutics, Inc. 89.4 Million USD -34.568%
Liquidia Corporation 120.43 Million USD 0.102%
Mustang Bio, Inc. 17.74 Million USD -578.095%
Immunovant, Inc. 666.71 Million USD 81.955%
Vericel Corporation 353.65 Million USD 65.982%
Quantum-Si incorporated 298.25 Million USD 59.662%
Arbutus Biopharma Corporation 144.4 Million USD 16.685%
XOMA Corporation 234.3 Million USD 48.653%
ARS Pharmaceuticals, Inc. 233.18 Million USD 48.407%
MiNK Therapeutics, Inc. 4.55 Million USD -2542.8%
Pasithea Therapeutics Corp. 26.11 Million USD -360.651%
Alpha Tau Medical Ltd. 107.38 Million USD -12.031%
Vaxcyte, Inc. 1.4 Billion USD 91.455%
Xenon Pharmaceuticals Inc. 964.79 Million USD 87.53%
Estrella Immunopharma, Inc. 4.45 Million USD -2601.0%
NeuroBo Pharmaceuticals, Inc. 22.78 Million USD -428.105%
Tempest Therapeutics, Inc. 51.6 Million USD -133.141%
Sol-Gel Technologies Ltd. 45.28 Million USD -165.656%
Rhythm Pharmaceuticals, Inc. 332.74 Million USD 63.844%
Soleno Therapeutics, Inc. 180.69 Million USD 33.418%
Enlivex Therapeutics Ltd. 36.83 Million USD -226.648%
PepGen Inc. 143.05 Million USD 15.899%
Moleculin Biotech, Inc. 38.21 Million USD -214.801%
United Therapeutics Corporation 7.16 Billion USD 98.321%
Solid Biosciences Inc. 164.93 Million USD 27.059%
BriaCell Therapeutics Corp. 5.87 Million USD -1948.745%
Conduit Pharmaceuticals Inc. 7.22 Million USD -1565.388%
Immuneering Corporation 102.58 Million USD -17.277%
Lixte Biotechnology Holdings, Inc. 4.3 Million USD -2692.255%
Silo Pharma, Inc. 7.74 Million USD -1453.13%
Telomir Pharmaceuticals, Inc. Common Stock 4.77 Million USD -2420.182%
Belite Bio, Inc 94.64 Million USD -27.119%
Pharming Group N.V. 462.85 Million USD 74.007%
Reviva Pharmaceuticals Holdings, Inc. 18.92 Million USD -535.752%
Bionomics Limited 27.64 Million USD -335.123%
Pyxis Oncology, Inc. 173.72 Million USD 30.749%
uniQure N.V. 831.68 Million USD 85.535%
Windtree Therapeutics, Inc. 32.4 Million USD -271.251%
GeoVax Labs, Inc. 9.28 Million USD -1195.969%
Poseida Therapeutics, Inc. 273.88 Million USD 56.074%
Altimmune, Inc. 210.64 Million USD 42.885%
Anebulo Pharmaceuticals, Inc. 4.07 Million USD -2853.702%
Alpha Tau Medical Ltd. 107.38 Million USD -12.031%
Peak Bio, Inc. 2.59 Million USD -4533.607%
SeaStar Medical Holding Corporation 3.51 Million USD -3324.642%
FibroBiologics, Inc. Common Stock 11.82 Million USD -917.745%
Benitec Biopharma Inc. 52.21 Million USD -130.43%
Zura Bio Limited 100.84 Million USD -19.302%
Amicus Therapeutics, Inc. 777.88 Million USD 84.534%
Salarius Pharmaceuticals, Inc. 6.58 Million USD -1726.573%
Compugen Ltd. 121.33 Million USD 0.846%
Elevai Labs, Inc. Common Stock 5.18 Million USD -2218.103%
argenx SE 4.54 Billion USD 97.351%
Zevra Therapeutics, Inc. 172.32 Million USD 30.186%
Nuvectis Pharma, Inc. 19.18 Million USD -527.092%
Spyre Therapeutics, Inc. 341.85 Million USD 64.808%
NKGen Biotech, Inc. Common Stock 34.77 Million USD -245.98%
Madrigal Pharmaceuticals, Inc. 640.54 Million USD 81.218%
PolyPid Ltd. 15.37 Million USD -682.642%
Aileron Therapeutics, Inc. 119.28 Million USD -0.856%
Plus Therapeutics, Inc. 11.38 Million USD -956.442%
Forte Biosciences, Inc. 38.98 Million USD -208.639%
Dianthus Therapeutics, Inc. 179.4 Million USD 32.941%
Instil Bio, Inc. 325.63 Million USD 63.054%
Elevation Oncology, Inc. 89.09 Million USD -35.039%
Immunome, Inc. 148.54 Million USD 19.007%
Verona Pharma plc 308.12 Million USD 60.955%
Enveric Biosciences, Inc. 6.11 Million USD -1866.621%
enGene Holdings Inc. Warrants 86.95 Million USD -38.35%
Shattuck Labs, Inc. 159.56 Million USD 24.602%
LENZ Therapeutics, Inc. 188.45 Million USD 36.161%
Design Therapeutics, Inc. 289.64 Million USD 58.463%
Leap Therapeutics, Inc. 72.82 Million USD -65.201%
Seelos Therapeutics, Inc. 5.41 Million USD -2120.518%
Achilles Therapeutics plc 161.45 Million USD 25.486%
Fractyl Health, Inc. Common Stock 76.21 Million USD -57.859%
Rani Therapeutics Holdings, Inc. 57.91 Million USD -107.728%
MoonLake Immunotherapeutics 526.54 Million USD 77.151%
Beam Therapeutics Inc. 1.45 Billion USD 91.758%
Moolec Science SA 24.05 Million USD -400.213%
Longboard Pharmaceuticals, Inc. 50.69 Million USD -137.307%
AEON Biopharma, Inc. 6.84 Million USD -1657.599%
Aadi Bioscience, Inc. 132.42 Million USD 9.149%
Enliven Therapeutics, Inc. 271.86 Million USD 55.748%
Iovance Biotherapeutics, Inc. 780.35 Million USD 84.583%
Taysha Gene Therapies, Inc. 266.99 Million USD 54.94%
Inovio Pharmaceuticals, Inc. 172.94 Million USD 30.436%
Athira Pharma, Inc. 160.24 Million USD 24.923%
HCW Biologics Inc. 28.51 Million USD -321.93%
XOMA Corporation 234.3 Million USD 48.653%
NeurAxis, Inc. 509.49 Thousand USD -23512.98%
Lumos Pharma, Inc. 40.63 Million USD -196.047%
enGene Holdings Inc. Common Stock 86.95 Million USD -38.35%
180 Life Sciences Corp. 5.25 Million USD -2187.446%
Nektar Therapeutics 398.03 Million USD 69.774%
NKGen Biotech, Inc. Warrants 34.77 Million USD -245.98%
Opiant Pharmaceuticals, Inc. 70.42 Million USD -70.824%
Arvinas, Inc. 1.3 Billion USD 90.778%
CERo Therapeutics Holdings, Inc. 8.56 Million USD -1305.363%
Palisade Bio, Inc. 14.05 Million USD -756.16%
Nutriband Inc. 7.51 Million USD -1500.442%
Tevogen Bio Holdings Inc. 17.03 Million USD -606.141%
CG Oncology, Inc. Common stock 199.3 Million USD 39.635%
Tourmaline Bio, Inc. 210.29 Million USD 42.791%
Merus N.V. 458.49 Million USD 73.76%
Omega Therapeutics, Inc. 204.36 Million USD 41.131%
Neurogene Inc. 222.57 Million USD 45.947%
Mirum Pharmaceuticals, Inc. 646.62 Million USD 81.394%
Kintara Therapeutics, Inc. 6.2 Million USD -1839.82%
CervoMed Inc. 9.97 Million USD -1106.392%
CARGO Therapeutics, Inc. Common Stock 453.03 Million USD 73.444%
Sesen Bio, Inc. 189.17 Million USD 36.404%
Quince Therapeutics, Inc. 180.2 Million USD 33.238%
Rezolute, Inc. 132.73 Million USD 9.364%
Clene Inc. 52.34 Million USD -129.854%
Indaptus Therapeutics, Inc. 14.92 Million USD -706.142%
BeyondSpring Inc. 24.8 Million USD -384.955%
Synlogic, Inc. 75.55 Million USD -59.242%
Allarity Therapeutics, Inc. 11.86 Million USD -914.227%
Phio Pharmaceuticals Corp. 9.36 Million USD -1184.789%
Peak Bio, Inc. 2.59 Million USD -4533.607%
Werewolf Therapeutics, Inc. 174.83 Million USD 31.187%
Krystal Biotech, Inc. 818.35 Million USD 85.299%
Karyopharm Therapeutics Inc. 240.43 Million USD 49.963%
SpringWorks Therapeutics, Inc. 725.78 Million USD 83.424%
Lipella Pharmaceuticals Inc. 3.57 Million USD -3263.204%
MannKind Corporation 475.19 Million USD 74.683%
Ikena Oncology, Inc. 192.09 Million USD 37.37%
Cyclerion Therapeutics, Inc. 13.37 Million USD -799.564%
Gyre Therapeutics, Inc. 116.53 Million USD -3.234%
Gossamer Bio, Inc. 311.91 Million USD 61.429%
CohBar, Inc. 16.36 Million USD -635.122%
Cognition Therapeutics, Inc. 35.16 Million USD -242.143%
NRx Pharmaceuticals, Inc. 7.31 Million USD -1544.671%
Legend Biotech Corporation 1.84 Billion USD 93.492%
Mural Oncology plc 301.74 Million USD 60.129%
Disc Medicine, Inc. 367.99 Million USD 67.307%
Champions Oncology, Inc. 26.13 Million USD -360.384%
REGENXBIO Inc. 573.97 Million USD 79.039%
Ensysce Biosciences, Inc. 2.7 Million USD -4342.536%
Anavex Life Sciences Corp. 154.38 Million USD 22.073%
Cellectar Biosciences, Inc. 12.07 Million USD -896.289%
Edgewise Therapeutics, Inc. 340.03 Million USD 64.619%
Vaxart, Inc. 91.83 Million USD -31.011%
PharmaCyte Biotech, Inc. 59.9 Million USD -100.834%
Aldeyra Therapeutics, Inc. 148.32 Million USD 18.89%
Cellectis S.A. 334.27 Million USD 64.009%
Longeveron Inc. 12.17 Million USD -887.91%
Repare Therapeutics Inc. 253.9 Million USD 52.616%
Sarepta Therapeutics, Inc. 3.26 Billion USD 96.315%
Inozyme Pharma, Inc. 200.84 Million USD 40.1%
Revolution Medicines, Inc. 2.08 Billion USD 94.24%
Nymox Pharmaceutical Corporation 1.62 Million USD -7303.548%
Third Harmonic Bio, Inc. 277.71 Million USD 56.679%
ArriVent BioPharma, Inc. Common Stock 163.09 Million USD 26.236%
AN2 Therapeutics, Inc. 138.74 Million USD 13.288%
Anixa Biosciences, Inc. 25.52 Million USD -371.388%
Vertex Pharmaceuticals Incorporated 22.73 Billion USD 99.471%
Denali Therapeutics Inc. 1.15 Billion USD 89.574%
Revelation Biosciences, Inc. 12.21 Million USD -885.11%
Veru Inc. 50.59 Million USD -137.781%
Corvus Pharmaceuticals, Inc. 45.55 Million USD -164.105%
Cingulate Inc. 3.49 Million USD -3345.793%
Passage Bio, Inc. 150.54 Million USD 20.085%
Context Therapeutics Inc. 16.06 Million USD -648.986%
Exicure, Inc. 11.58 Million USD -938.926%
Day One Biopharmaceuticals, Inc. 376.04 Million USD 68.007%
Oramed Pharmaceuticals Inc. 161.64 Million USD 25.572%
Scinai Immunotherapeutics Ltd. 17.47 Million USD -588.574%
Nuvalent, Inc. 732.38 Million USD 83.573%
ABVC BioPharma, Inc. 14.94 Million USD -705.052%
Carisma Therapeutics, Inc. 89.55 Million USD -34.341%
Unicycive Therapeutics, Inc. 14.19 Million USD -747.774%
OmniAb, Inc. 401.98 Million USD 70.072%
Anew Medical, Inc. 19.45 Million USD -518.359%
Fennec Pharmaceuticals Inc. 26.72 Million USD -350.143%
Lipocine Inc. 23 Million USD -423.052%
Lexeo Therapeutics, Inc. Common Stock 139.8 Million USD 13.947%
Nautilus Biotechnology, Inc. 305.56 Million USD 60.628%
SAB Biotherapeutics, Inc. 83.94 Million USD -43.324%
G1 Therapeutics, Inc. 121.54 Million USD 1.014%
Bellerophon Therapeutics, Inc. 7.93 Million USD -1416.165%
Sage Therapeutics, Inc. 882.27 Million USD 86.364%
Ocugen, Inc. 64.54 Million USD -86.388%
Mind Medicine (MindMed) Inc. 124.54 Million USD 3.399%
Q32 Bio Inc. 306.11 Million USD 60.699%
Brainstorm Cell Therapeutics Inc. 4.2 Million USD -2759.022%
Alumis Inc. Common Stock 89.61 Million USD -34.254%
Equillium, Inc. 50.53 Million USD -138.092%
Kyverna Therapeutics, Inc. 75.19 Million USD -59.994%
Coya Therapeutics, Inc. 41.27 Million USD -191.489%
CNS Pharmaceuticals, Inc. 1.7 Million USD -6973.372%
Dominari Holdings Inc. 57.55 Million USD -109.02%
Edesa Biotech, Inc. 8.89 Million USD -1253.225%
vTv Therapeutics Inc. 11.01 Million USD -991.919%
Bio-Techne Corporation 2.81 Billion USD 95.723%
Agios Pharmaceuticals, Inc. 937.11 Million USD 87.162%
Harmony Biosciences Holdings, Inc. 811.44 Million USD 85.174%
Prelude Therapeutics Incorporated 277.66 Million USD 56.672%
Candel Therapeutics, Inc. 41.7 Million USD -188.494%
iTeos Therapeutics, Inc. 667.58 Million USD 81.979%
Nkarta, Inc. 378.88 Million USD 68.247%
BioCardia, Inc. 2.98 Million USD -3927.709%
Iterum Therapeutics plc 26.25 Million USD -358.158%